CAPTRUST Financial Advisors
NVO

CAPTRUST Financial Advisors’s Novo Nordisk NVO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Sell
116,809
-26,196
-18% -$1.13M 0.01% 770
2026
Q1 		$5.25M Buy
143,005
+23,442
+20% +$1.11M 0.01% 746
2025
Q4 		$6.08M Sell
119,563
-31,782
-21% -$1.63M 0.01% 615
2025
Q3 		$8.4M Sell
151,345
-9,296
-6% -$544K 0.02% 515
2025
Q2 		$11.1M Sell
160,641
-28,101
-15% -$1.91M 0.02% 440
2025
Q1 		$13.1M Buy
188,742
+52,156
+38% +$4.31M 0.03% 366
2024
Q4 		$11.7M Sell
136,586
-18,626
-12% -$2.01M 0.03% 337
2024
Q3 		$18.5M Sell
155,212
-5,611
-3% -$748K 0.05% 256
2024
Q2 		$23M Buy
160,823
+10,997
+7% +$1.46M 0.07% 197
2024
Q1 		$19.2M Buy
149,826
+4,947
+3% +$589K 0.07% 228
2023
Q4 		$15M Buy
144,879
+34,278
+31% +$3.39M 0.05% 286
2023
Q3 		$10.1M Buy
110,601
+28,361
+34% +$2.5M 0.04% 337
2023
Q2 		$6.65M Buy
82,240
+2,564
+3% +$209K 0.03% 416
2023
Q1 		$6.34M Buy
79,676
+8,740
+12% +$620K 0.03% 402
2022
Q4 		$4.8M Buy
70,936
+6,994
+11% +$410K 0.02% 442
2022
Q3 		$3.19M Buy
63,942
+14,374
+29% +$770K 0.02% 531
2022
Q2 		$2.76M Buy
49,568
+6,246
+14% +$347K 0.02% 521
2022
Q1 		$2.43M Buy
43,322
+5,858
+16% +$301K 0.02% 550
2021
Q4 		$2.1M Buy
37,464
+12,000
+47% +$650K 0.01% 554
2021
Q3 		$1.22M Buy
25,464
+274
+1% +$13.2K 0.01% 670
2021
Q2 		$1.05M Buy
25,190
+1,532
+6% +$59.4K 0.01% 701
2021
Q1 		$808K Buy
23,658
+1,628
+7% +$58K 0.01% 778
2020
Q4 		$769K Sell
22,030
-4,300
-16% -$149K 0.01% 690
2020
Q3 		$912K Buy
26,330
+3,126
+13% +$104K 0.02% 539
2020
Q2 		$762K Buy
23,204
+5,912
+34% +$189K 0.01% 575
2020
Q1 		$523K Buy
17,292
+266
+2% +$7.92K 0.01% 582
2019
Q4 		$497K Buy
+17,026
New +$471K 0.01% 688

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CAPTRUST Financial Advisors's NVO Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $1.13M and leaving 116,809 shares worth $5.6M. The position accounts for 0.01% of the portfolio, ranked #770.

CAPTRUST Financial Advisors first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $23M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • CAPTRUST Financial Advisors held 116,809 shares of Novo Nordisk worth $5.6M as of Q2 2026.
  • CAPTRUST Financial Advisors sold 26,196 Novo Nordisk shares in Q2 2026, an estimated $1.13M.
  • Novo Nordisk made up 0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #770 holding.
  • CAPTRUST Financial Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • CAPTRUST Financial Advisors's Novo Nordisk position peaked at $23M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.